Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma

Name: Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma
License: Public Domain

Third Affiliated Hospital, Sun Yat-Sen University

ClinicalTrials.gov · Datasets · License: Public Domain

hepatocellular carcinoma, atezolizumab plus bevacizumab, transarterial chemoembolization

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 152415
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.